{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:50:32Z","timestamp":1791618632700,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Community","award":["FIGHT-MG\/HEALTH-2009-242-210"],"award-info":[{"award-number":["FIGHT-MG\/HEALTH-2009-242-210"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Predisposition to autoimmunity and inflammatory disorders is observed in patients with fragile X-associated syndromes. These patients have increased numbers of CGG triplets in the 5\u2019 UTR region of <jats:italic>FMR1<\/jats:italic> (Fragile X Mental Retardation 1) gene, that affects its expression. <jats:italic>FMR1<\/jats:italic> is decreased in the thymus of myasthenia gravis (MG) patients, a prototypical autoimmune disease. We thus analyzed the number of CGG triplets in <jats:italic>FMR1<\/jats:italic> in MG, and explored the regulatory mechanisms affecting thymic <jats:italic>FMR1<\/jats:italic> expression. We measured the number of CGGs using thymic DNA from MG and controls, but no abnormalities in CGGs were found in MG that could explain thymic decrease of <jats:italic>FMR1<\/jats:italic>. We next analyzed by RT-PCR the expression of <jats:italic>FMR1<\/jats:italic> and its transcription factors in thymic samples, and in thymic epithelial cell cultures in response to inflammatory stimuli. In control thymuses, <jats:italic>FMR1<\/jats:italic> expression was higher in males than females, and correlated with <jats:italic>CTCF<\/jats:italic> (CCCTC-binding factor) expression. In MG thymuses, decreased expression of <jats:italic>FMR1<\/jats:italic> was correlated with both <jats:italic>CTCF<\/jats:italic> and <jats:italic>MAX<\/jats:italic> (Myc-associated factor X) expression. Changes in <jats:italic>FMR1<\/jats:italic> expression were supported by western blot analyses for FMRP. In addition, we demonstrated that <jats:italic>FMR1, CTCF<\/jats:italic> and <jats:italic>MAX<\/jats:italic> expression in thymic epithelial cells was also sensitive to inflammatory signals. Our results suggest that <jats:italic>FMR1<\/jats:italic> could play a central role in the thymus and autoimmunity. First, in relation with the higher susceptibility of females to autoimmune diseases. Second, due to the modulation of its expression by inflammatory signals that are known to be altered in MG thymuses.<\/jats:p>","DOI":"10.1186\/s12974-021-02311-y","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T07:06:48Z","timestamp":1637132808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis"],"prefix":"10.1186","volume":"18","author":[{"given":"Scott","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odessa-Maud","family":"Fayet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Truffault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Provost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abderaouf","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Bonnefont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7522-5974","authenticated-orcid":false,"given":"Rozen","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"2311_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/0092-8674(91)90283-5","volume":"67","author":"YH Fu","year":"1991","unstructured":"Fu YH, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell. 1991;67:1047\u201358.","journal-title":"Cell"},{"key":"2311_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5334\/tohm.233","volume":"4","author":"DA Hall","year":"2014","unstructured":"Hall DA. In the Gray Zone in the Fragile X Gene: What are the Key Unanswered Clinical and Biological Questions? Tremor Other Hyperkinet Mov (N Y). 2014;4:208.","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"2311_CR3","doi-asserted-by":"publisher","first-page":"J74","DOI":"10.1016\/j.jaut.2011.05.016","volume":"38","author":"N Gleicher","year":"2012","unstructured":"Gleicher N, Weghofer A, Barad DH. Cutting edge assessment of the impact of autoimmunity on female reproductive success. J Autoimmun. 2012;38:J74-80.","journal-title":"J Autoimmun"},{"key":"2311_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2014.00309","volume":"5","author":"MR Mailick","year":"2014","unstructured":"Mailick MR, Hong J, Rathouz P, Baker MW, Greenberg JS, Smith L, et al. Low-normal FMR1 CGG repeat length: Phenotypic associations. Front Genet. 2014;5:1\u20138.","journal-title":"Front Genet"},{"key":"2311_CR5","first-page":"4","volume":"13","author":"Q Wang","year":"2018","unstructured":"Wang Q, Barad DH, Darmon SK, Kushnir VA, Wu YG, Lazzaroni-Tealdi E, et al. Reduced RNA expression of the FMR1 gene in women with low CGG n < 26 repeats. PLoS ONE. 2018;13:4\u201315.","journal-title":"PLoS ONE"},{"key":"2311_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s12551-020-00730-4","volume":"12","author":"C Malecki","year":"2020","unstructured":"Malecki C, Hambly BD, Jeremy RW, Robertson EN. The RNA-binding fragile-X mental retardation protein and its role beyond the brain. Biophys Rev Biophysical Reviews. 2020;12:903\u201316.","journal-title":"Biophys Rev Biophysical Reviews"},{"key":"2311_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/ng0193-36","volume":"3","author":"HL Hinds","year":"1993","unstructured":"Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, et al. Tissue specific expression of FMR\u20131 provides evidence for a functional role in fragile X syndrome. Nat Genet. 1993;3:36\u201343.","journal-title":"Nat Genet"},{"key":"2311_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaut.2009.03.004","volume":"33","author":"L Persani","year":"2009","unstructured":"Persani L, Rossetti R, Cacciatore C, Bonomi M. Primary Ovarian Insufficiency: X chromosome defects and autoimmunity. J Autoimmun. 2009;33:35\u201341.","journal-title":"J Autoimmun"},{"key":"2311_CR9","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/ajmg.a.35569","volume":"158A","author":"TI Winarni","year":"2012","unstructured":"Winarni TI, Chonchaiya W, Sumekar TA, Ashwood P, Morales GM, Tassone F, et al. Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A. 2012;158A:2473\u201381.","journal-title":"Am J Med Genet A"},{"key":"2311_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","volume":"52","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Le Panse R. Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun. 2014;52:90\u2013100.","journal-title":"J Autoimmun"},{"key":"2311_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.autrev.2018.01.008","volume":"17","author":"MA Cron","year":"2018","unstructured":"Cron MA, Maillard S, Deslile F, Samson N, Truffault F, Foti M, et al. Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues. Autoimmun Rev. 2018;17:588\u2013600.","journal-title":"Autoimmun Rev"},{"key":"2311_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1146\/annurev.immunol.23.021704.115601","volume":"24","author":"B Kyewski","year":"2006","unstructured":"Kyewski B, Klein L. A central role for central tolerance. Annu Rev Immunol. 2006;24:571\u2013606.","journal-title":"Annu Rev Immunol"},{"key":"2311_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/jmedgenet-2013-102021","volume":"51","author":"DI Pretto","year":"2014","unstructured":"Pretto DI, Mendoza-Morales G, Lo J, Cao R, Hadd A, Latham GJ, et al. CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. J Med Genet. 2014;51:309\u201318.","journal-title":"J Med Genet"},{"key":"2311_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ajmg.a.35833","volume":"161","author":"SL Nolin","year":"2013","unstructured":"Nolin SL, Sah S, Glicksman A, Sherman SL, Allen E, Berry-Kravis E, et al. Fragile X AGG analysis provides new risk predictions for 45\u201369 repeat alleles. Am J Med Genet Part A. 2013;161:771\u20138.","journal-title":"Am J Med Genet Part A"},{"key":"2311_CR15","doi-asserted-by":"crossref","unstructured":"Brackett DM, Qing F, Amieux PS, Sellers DL, Horner PJ, Morris DR. Fmr1 Transcript Isoforms: Association with Polyribosomes; Regional and Developmental Expression in Mouse Brain. PLoS One. 2013; 8: e58296.","DOI":"10.1371\/journal.pone.0058296"},{"issue":"63","key":"2311_CR16","first-page":"1","volume":"21","author":"WJ Yang","year":"2020","unstructured":"Yang WJ, Yang WJ, Yan AZ, Xu YJ, Guo XY, Guo XY, et al. Further identification of a 140bp sequence from amid intron 9 of human FMR1 gene as a new exon. BMC Genet. 2020;21(63):1\u201310.","journal-title":"BMC Genet"},{"key":"2311_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1178641818825268","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J, Wang G, He W-W, Losh M, Berry-Kravis E, Funk WE. Expression and Characterization of Human Fragile X Mental Retardation Protein Isoforms and Interacting Proteins in Human Cells. Proteomics Insights. 2019;10:1\u20139.","journal-title":"Proteomics Insights"},{"key":"2311_CR18","doi-asserted-by":"crossref","unstructured":"Kumari D, Usdin K. Interaction of the transcription factors USF1, USF2, and \u03b1-Pal\/Nrf-1 with the FMR1 promoter. Implications for Fragile X mental retardation syndrome. J Biol Chem. 2001;276:4357\u201364.","DOI":"10.1074\/jbc.M009629200"},{"key":"2311_CR19","doi-asserted-by":"crossref","unstructured":"Lanni S, Goracci M, Borrelli L, Mancano G, Chiurazzi P, Moscato U, et al. Role of CTCF protein in regulating FMR1 locus transcription. PLoS Genet. 2013;9:e1003601.","DOI":"10.1371\/journal.pgen.1003601"},{"key":"2311_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.it.2013.10.006","volume":"35","author":"JG Markle","year":"2014","unstructured":"Markle JG, Fish EN. SeXX matters in immunity. Trends Immunol. 2014;35:97\u2013104.","journal-title":"Trends Immunol"},{"key":"2311_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ni.3638","volume":"18","author":"Y Herzig","year":"2017","unstructured":"Herzig Y, Nevo S, Bornstein C, Brezis MR, Ben-Hur S, Shkedy A, et al. Transcriptional programs that control expression of the autoimmune regulator gene Aire. Nat Immunol. 2017;18:161\u201372.","journal-title":"Nat Immunol"},{"key":"2311_CR22","doi-asserted-by":"crossref","unstructured":"Stik G, Vidal E, Barrero M, Cuartero S, Vila-casades\u00fas M, Mendieta-esteban J, et al. CTCF is dispensable for immune cell transdifferentiation but facilitates an acute inflammatory response. Nat Genet [Internet]. Springer US; 2020;52: 655\u2013661.","DOI":"10.1038\/s41588-020-0643-0"},{"key":"2311_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ana.23791","volume":"73","author":"P Cufi","year":"2013","unstructured":"Cufi P, Dragin N, Weiss JM, Martinez-Martinez P, De Baets MH, Roussin R, et al. Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis. Ann Neurol. 2013;73:281\u201393.","journal-title":"Ann Neurol"},{"key":"2311_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","volume":"105","author":"A Balandina","year":"2005","unstructured":"Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood. 2005;105:735\u201341.","journal-title":"Blood"},{"key":"2311_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0094475","volume":"9","author":"M Careaga","year":"2014","unstructured":"Careaga M, Rose D, Tassone F, Berman RF, Hagerman R, Ashwood P. Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: Link between FMRI CGG repeat number and decreased cytokine responses. PLoS ONE. 2014;9:1\u20138.","journal-title":"PLoS ONE"},{"key":"2311_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-9-238","volume":"9","author":"D Marek","year":"2012","unstructured":"Marek D, Papin S, Ellefsen K, Niederhauser J, Isidor N, Ransijn A, et al. Carriers of the fragile X mental retardation 1 (FMR1) premutation allele present with increased levels of cytokine IL-10. J Neuroinflammation. 2012;9:1\u20138.","journal-title":"J Neuroinflammation"},{"key":"2311_CR27","doi-asserted-by":"crossref","unstructured":"Careaga M, Noyon T, Basuta K, Van de Water J, Tassone F, Hagerman RJ, et al. Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome. J Neuroinflammation. 2014;11:1\u201310.","DOI":"10.1186\/1742-2094-11-110"},{"key":"2311_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1083\/jcb.201607093","volume":"216","author":"RM O\u2019Connor","year":"2017","unstructured":"O\u2019Connor RM, Stone EF, Wayne CR, Marcinkevicius EV, Ulgherait M, Delventhal R, et al. A Drosophila model of Fragile X syndrome exhibits defects in phagocytosis by innate immune cells. J Cell Biol. 2017;216:595\u2013605.","journal-title":"J Cell Biol"},{"key":"2311_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-015-0061-9","volume":"6","author":"D Prilutsky","year":"2015","unstructured":"Prilutsky D, Kho AT, Palmer NP, Bhakar AL, Smedemark-Margulies N, Kong SW, et al. Gene expression analysis in Fmr1KO mice identifies an immunological signature in brain tissue and mGluR5-related signaling in primary neuronal cultures. Mol Autism. 2015;6:1\u201314.","journal-title":"Mol Autism"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02311-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-021-02311-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02311-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T07:10:02Z","timestamp":1637133002000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-021-02311-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2311"],"URL":"https:\/\/doi.org\/10.1186\/s12974-021-02311-y","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies on blood and thymic samples were approved by local ethics committees (RCB 2006-A00164-47 and RCB 2010-A00250-39) and informed consent forms have been collected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}